Oncology
Global

Oncology Experts

Haibin Tian

Researcher
Deparment of Cancer Imaging and Metabolism
Moffitt Cancer Center
United States of America

Haibin Tian

Biography

Dr. Haibin Tian is affiliated to Deparment of Cancer Imaging and Metabolism, Moffitt Cancer Center. Dr. Haibin Tian is currently providing services as Researcher. Dr. Haibin Tian has authored and co-authored multiple peer-reviewed scientific papers and presented works at many national and International conferences. Dr. Haibin Tian contributions have acclaimed recognition from honourable subject experts around the world. Dr. Haibin Tian is actively associated with different societies and academies. Dr. Haibin Tian academic career is decorated with several reputed awards and funding. Dr. Haibin Tian research interests include My major research interest is in developing selective radiotracers for measuring its expression in vivo utilizing positron emission tomography (PET).  This research area has a lot of room for development and there is great prospects for synthesizing new imaging tracers that will be very useful in the iagnosis and treatment of cancer and neuronal systems. .

Research Interest

My major research interest is in developing selective radiotracers for measuring its expression in vivo utilizing positron emission tomography (PET).  This research area has a lot of room for development and there is great prospects for synthesizing new imaging tracers that will be very useful in the iagnosis and treatment of cancer and neuronal systems. 

Publications

  • Kam Y, Das T, Tian H, Foroutan P, Ruiz E, Martinez G, Minton S, Gillies RJ, Gatenby RA. Sweat but no gain: inhibiting proliferation of multidrug resistant cancer cells with “ersatzdroges”. International journal of cancer. 2015 Feb 15;136(4).

  • Huang X, Xiao X, Gillies RJ, Tian H. Design and automated production of 11C-alpha-methyl-l-tryptophan (11C-AMT). Nuclear medicine and biology. 2016 May 31;43(5):303-8.

  • Huang X, Pan Z, Doligalski ML, Xiao X, Ruiz E, Budzevich MM, Tian H. Evaluation of radiofluorinated carboximidamides as potential IDO-targeted PET tracers for cancer imaging. Oncotarget. 2017 Jul 18;8(29):46900.

Global Experts from United States of America

Global Experts in Subject

Share This Profile
Recommended Conferences
View more